A Phase 1 Study of Cizutamig in IgE Mediated Diseases | MicrobiomeTrials← Back to trialsNCT07408869
A Phase 1 Study of Cizutamig in IgE Mediated Diseases
WITHDRAWNPHASE1INTERVENTIONAL
Trial Details
Start: 2026-04Est. Completion: 2026-12
Enrollment target: 0 participants Locations- Nucleus Network, Melbourne, Victoria, Australia
Other microbiome trials you might be interested in
Fish AllergyFood HypersensitivityIgE-Mediated Food Allergy
Fish allergy is one of the leading causes of food-induced allergic reactions in children, but the clinical presentation …
Multiple LocationsEst. completion Dec 30, 2027
Type 1 Diabetes Mellitus
This is a non-randomized, parallel-controlled, single-center, open-label clinical trial designed to evaluate the efficac…
Nanjing, ChinaEst. completion Dec 31, 2028